标普和纳斯达克内在价值 联系我们

Windtree Therapeutics, Inc. WINT OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
43/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Windtree Therapeutics, Inc. (WINT) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 41/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score
43/100
SG Score
View full scorecard →
价值
N/A
No coverage
~
未來
55/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
健康
33/100
Debt-to-Equity & liquidity
→ Health
护城河
28/100
→ Income
成长
100/100
→ Income
收入
N/A
No coverage

估值概览 — WINT

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-104.35
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2015 $-21,380,800.00 $987K $-55.17M -5589.7%
2016 $-12,815,300.00 $2.04M $-39.49M -1933.9%
2017 $-3,258,910.00 $1.49M $-18.45M -1242.2%
2018 $-1,044,300.00 $1.79M $-20.53M -1148.4%
2019 $-113,138.00 $198K $-29.86M -15081.8%
2020 $-93,616.00 $0.00 $-30.28M -
2021 $-122,924.00 $0.00 $-67.64M -
2022 $-56,011.00 $0.00 $-39.21M -
2023 $-4,711.54 $0.00 $-20.29M -
2024 $-104.35 $0.00 $-5.49M -
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言